INTL MEDICATION FDA Approval ANDA 072076

ANDA 072076

INTL MEDICATION

FDA Drug Application

Application #072076

Application Sponsors

ANDA 072076INTL MEDICATION

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTION1MG/ML0NALOXONE HYDROCHLORIDENALOXONE HYDROCHLORIDE

FDA Submissions

ORIG1AP1988-03-24
LABELING; LabelingSUPPL2AP1988-05-20
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1993-10-29
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1998-01-14
LABELING; LabelingSUPPL8AP1995-02-06
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1994-06-17
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1995-09-19
LABELING; LabelingSUPPL11AP1996-06-10
MANUF (CMC); Manufacturing (CMC)SUPPL12AP2002-07-18
LABELING; LabelingSUPPL13AP2002-07-18
MANUF (CMC); Manufacturing (CMC)SUPPL14AP2008-06-04
LABELING; LabelingSUPPL17AP2013-10-30STANDARD
LABELING; LabelingSUPPL19AP2015-07-31STANDARD

Submissions Property Types

SUPPL6Null0
SUPPL7Null0
SUPPL9Null0
SUPPL10Null0
SUPPL12Null0
SUPPL14Null0
SUPPL17Null7
SUPPL19Null15

TE Codes

001PrescriptionAP

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 72076
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.